Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Diffuse Intrinsic Pontine Glioma × Irinotecan × Clear all

Phase

Phase 1/2 2 Phase EARLY_PHASE1 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 3 Sarcoma 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Gliosarcoma 1 Glioblastoma 1 Diffuse Intrinsic Pontine Glioma 1 Colonic Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

lorlatinib 1 larotrectinib 1 fimepinostat 1 Temozolomide 1 Irinotecan 1 Gemcitabine 1 CUDC-907 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00890786 2018-05-02

A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas

Children's Hospital Medical Center, Cincinnati

Phase EARLY_PHASE1 Completed

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡